BioCryst to Report Third Quarter 2025 Financial Results on November 3
Provided By GlobeNewswire
Last update: Oct 20, 2025
RESEARCH TRIANGLE PARK, N.C., Oct. 20, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its third quarter 2025 financial results on Monday, November 3, 2025.
Read more at globenewswire.com
